Programme
(Preliminary)
Wednesday June 11th - Presymposium
08:30 - 09:45
|
Registration for presymposium and entire congress
|
09:45 - 10:00
|
Welcome
|
10:00 - 11:00
|
Norway
Amyloidosis |
11:00 - 11:10
|
Break
|
11:10 - 12:10
|
Denmark
CVD in CKD
|
12:10 - 12:20
|
Break
|
12:20 - 13:20
|
Sweden
Different aspects on contributing mechanisms in ANCA-associated vasculitis
|
13:20 - 14:50
|
Lunch break
|
13:45 - 14:45
|
Lunch symposium - sponsored by Novo Nordisk (Gold sponsor)
Metabolic and Renal Interplay: Exploring Obesity, Diabetes, and Chronic Kidney Disease Interconnected Metabolic Pathways: Obesity, Diabetes, and Chronic Kidney Disease Revolutionizing Metabolic Nephropathy Management: The Emergence of GLP-1 Receptor Agonists |
14:50 - 15:50
|
Iceland
|
15:50 - 16:00
|
Break
|
16:00 - 17:00
|
Finland
|
17:00 - 17:15
|
Break
|
17:15 - 17:25
|
NSN Congress Opening
|
17:25 - 17:45
|
Best abstract
|
Thursday June 12th - Congress
08:30 - 09:30
|
Expert panel discussion: Early CKD detection, prevention and referral | TBD
|
09:30 - 09:45
|
Break
|
09:45 - 10:15
|
Antihypertensive treatment in CKD | Daniel Gordin
|
10:15 - 10:45
|
Hypertension in Pregnancy | TBD
|
10:45 - 11:00
|
Break
|
11:00 - 12:05
|
State of the art 1
Quality of life for elderly on dialysis therapy | Edwina Brown |
12:05 - 12:30
|
Break
|
12:30 - 13:30
|
Lunch symposium - sponsored by Vantive (Platinum sponsor)
Extending Lives Expanding Possibilities PD cases: You decide - Experts guide. Chairman: Helga Gudmundsdottir, Nephrologist at OUS, Ullevål. Norway Treating patients with PD allows for increased freedom for life compared to HD. Modern PD is beneficial for patient outcomes and healthcare costs, while introduction of remote patient management systems has enabled safer treatment in patients’ homes. Join our session to hear how leading Nordic nephrologists in PD care see the challenges, and how they would overcome them with evidence based solutions. |
13:30 - 13:40
|
Break
|
13:40 - 14:40
|
Debunking the myths of PD | TBD
Maintaining a high prevalence of patients in PD | Helga Gudmundsdottir Peritoneal dialysis in children | TBD |
14:40 - 14:50
|
Break
|
14:50 - 16:05
|
Poster Session
|
16:05 - 16:30
|
Break
|
16:30 - 17:30
|
Industry symposium sponsored by Astra Zeneca (Platinum Sponsor)
Title TBD |
17:30 - 17:40
|
Break
|
17:40 - 18:00
|
Best abstract
|
19:00 - 21:00
|
Get Together Oslo City Hall (Rådhuset)
|
Friday June 13th - Congress
08:30 - 09:30
|
New guidelines and new treatments – update on CMV and BKV after kidney transplantation | Ilkka Helanterä
EBV and PTLD | Lene Ludvigsen |
09:30 - 09:45
|
Break
|
09:45 - 10:35
|
Cardiovascular screening before kidney transplantation | Simon Winther
TBD | TBD Cardiovascular profylaxis posttx | Trond Jensen |
10:35 - 10:45
|
Break
|
10:45 - 12:05
|
State of the art 2 and plenary discussion
Pancreas islet cell transplantation | Per-Ola Carlsson |
12:05 - 12:30
|
Break
|
12:30 - 13:30
|
Lunch symposium - sponsored by CSL Vifor (Platinum sponsor)
What is the role of the complement system in ANCA-associated vasculitis? | Associate professor Sophie Ohlsson, Lund University New therapeutic options in IgAN – a clinical perspective | Professor Adrian Schreiber, Charité, University Hospital Berlin |
13:30 - 13:40
|
Break
|
13:40 - 14:40
|
CKD MBD: The spectrum of bone diseases in chronic kidney disease | TBD
CKD MBD: Preventing fractures in patients with CKD | TBD |
14:40 - 14:50
|
Break
|
14:50 - 16:05
|
Poster Session
|
16:05 - 16:30
|
Break
|
16:30 - 17:30
|
Industry symposium - sponsored by Boehringer Ingelheim (Gold Sponsor)
Title TBD |
17:30 - 17:40
|
Break
|
17:40 - 18:00
|
Best abstract 2
|
19:00 -
|
Congress dinner
|
Saturday June 14th - Congress
09:00 - 10:30
|
State of the art 3 and plenary discussion
Immunosuppressive therapy in IgA nephritis | Jonathan Barratt and Yngvar Haaskjold Setting the Scene and Current Goals in IgA Nephropathy | Jonathan Barratt Prognostic Models in IgA Nephropathy | Yngvar Haaskjold Immunosuppressive Treatments in IgA Nephropathy: When, Which, and Duration? | Jonathan Barratt IgA Vasculitis: Similarities and Contrasts with IgA Nephropathy | Jonathan Barratt |
10:30 - 10:45
|
Break
|
10:45 - 11:45
|
CAR-T cell theraphy in immune-mediated kidney diseases: future prospects an safety | Yngvar Haaskjold
Advanced molecular profiling of FFPE kidney tissues | Øystein Eikrem |
11:45 - 12:05
|
Break
|
12:05 - 13:05
|
Lunch symposium - sponsored by Medice Nordic (Gold sponsor)
Vadadustat INNO2VATIVE anaemia management for dialysis patients |
13:05 - 13:15
|
Congress conclusion
|